biosensors
Wyss Institute Licenses Electrochemical Sensing Technology to StataDx
StataDx has obtained a license to eRapid, an affinity-based, multiplexed, electrochemical sensing technology developed at Harvard's Wyss Institute.Â
Hopkins researchers are validating a nanosensor platform to detect SARS-CoV-2 and other viruses that consists of a single-use chip and handheld spectrometer.
Liverpool Spinout iiDiagnostics to Offer Contract Research Services, Infectious Disease Tests
Premium
The Liverpool School of Tropical Medicine spinout will provide diverse diagnostics services to partners, as well as cultivate its own menu of platforms and tests.
Momm Diagnostics is currently benchmarking its offering against other tests for preeclampsia, while courting investors to support a new phase of development.
The EU-backed project, called Serena, envisions the deployment of a multisensor platform that can detect microRNAs and long noncoding RNAs associated with the disease.